One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to The American Journal of Emergency Medicine
- Atrial fibrillation in congestive heart failure.Heart Fail Clin. 2010; 6: 187-200https://doi.org/10.1016/j.hfc.2009.11.001
- Atrial fibrillation and heart failure: treatment considerations for a dual epidemic.Circulation. 2009; 119: 2516-2525https://doi.org/10.1161/CIRCULATIONAHA.108.821306
- 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.J Am Coll Cardiol. 2013; 62e147-239https://doi.org/10.1016/j.jacc.2013.05.019
- 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society.J Am Coll Cardiol. 2014; 64e1-76https://doi.org/10.1016/j.jacc.2014.03.022
- Drugs that may cause or exacerbate heart failure: a scientific statement from the American Heart Association.Circulation. 2016; 134: e32-69https://doi.org/10.1161/CIR.0000000000000426
- The effect of diltiazem on mortality and reinfarction after myocardial infarction.N Engl J Med. 1988; 319: 385-392https://doi.org/10.1056/NEJM198808183190701
- Comparison of the effectiveness of intravenous diltiazem and metoprolol in the management of rapid ventricular rate in atrial fibrillation.Emerg Med J. 2005; 22 (doi:22/6/411 [pii]): 411-414
- Diltiazem vs. metoprolol in the management of atrial fibrillation or flutter with rapid ventricular rate in the emergency department.J Emerg Med. 2015; 49: 175-182https://doi.org/10.1016/j.jemermed.2015.01.014
- Safety and efficiency of calcium channel blockers versus beta-blockers for rate control in patients with atrial fibrillation and no acute underlying medical illness.Acad Emerg Med. 2013; 20: 222-230https://doi.org/10.1111/acem.12091
- Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support.J Biomed Inf. 2009; 42: 377-381
- Comparison of the rapid emergency medicine score and APACHE II in nonsurgical emergency department patients.Acad Emerg Med. 2003; 10: 1040-1048https://doi.org/10.1197/S1069-6563(03)00342-7
- Intravenous diltiazem for the treatment of patients with atrial fibrillation or flutter and moderate to severe congestive heart failure.Am J Cardiol. 1994; 74 (doi:0002-9149(94)90580-0 [pii]): 884-889
- Implications of using different definitions on outcomes in worsening heart failure.Circ Fail. 2016; 9https://doi.org/10.1161/CIRCHEARTFAILURE.116.003048
- In-hospital worsening heart failure.Eur J Heart Fail. 2015; 17: 1104-1113https://doi.org/10.1002/ejhf.333
- Treating rapid atrial fibrillation in acute decompensated heart failure: metoprolol and diltiazem are equally safe, yet metoprolol increases conversion to sinus rhythm.J Card Fail. 2014; 20: S41
- Central and renal hemodynamic effects and hormonal response to diltiazem in severe congestive heart failure.Am J Cardiol. 1987; 59 (doi:0002-9149(87)90862-9 [pii]): 1138-1143
- Beneficial hemodynamic effects of intravenous and oral diltiazem in severe congestive heart failure.J Am Coll Cardiol. 1984; 3: 1044-1050
- Hemodynamic effects of intravenous diltiazem with impaired left ventricular function.Am J Cardiol. 1984; 54 (doi:S0002-9149(84)80199-X [pii]): 733-737
- Achieving a maximally tolerated β-blocker dose in heart failure patients: is there room for improvement?.J Am Coll Cardiol. 2017; 69: 2542-2550https://doi.org/10.1016/j.jacc.2017.03.563
☆Sources of support: None.
☆☆Conflict of interest: No listed authors have any conflict of interest to the subject matter in this manuscript.